ASNS: Actelis Networks, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 5.30
Enterprise Value ($M) 8.27
Book Value ($M) -1.67
Book Value / Share -0.50
Price / Book -3.18
NCAV ($M) -5.99
NCAV / Share -1.79
Price / NCAV -0.88

Profitability (mra)
Return on Invested Capital (ROIC) -1.97
Return on Assets (ROA) -0.47
Return on Equity (ROE) -4.96

Liquidity (mrq)
Quick Ratio 0.40
Current Ratio 0.70

Balance Sheet (mrq) ($M)
Current Assets 6.19
Assets 10.52
Liabilities 12.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.61
Operating Income -7.36
Net Income -6.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -6.58
Cash from Investing 3.82
Cash from Financing 3.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Armistice Capital, Llc 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 150,142 716,684 20.95
2024-07-25 555,935 2,047,427 27.15
2024-07-24 61,301 359,197 17.07
2024-07-23 90,115 475,010 18.97
2024-07-22 193,314 563,844 34.29

(click for more detail)

Similar Companies
APTO – Aptose Biosciences Inc. APVO – Aptevo Therapeutics Inc.
ARTL – Artelo Biosciences, Inc. ASRT – Assertio Holdings, Inc.
ATNF – 180 Life Sciences Corp.


Financial data and stock pages provided by
Fintel.io